The DOI matches its Crossref record; 410 of the 410 references it cites were found in a registry or an index.
The role of SOX family members in solid tumours and metastasis
Open accessAbstract
Cancer is a heavy burden for humans across the world with high morbidity and mortality. Transcription factors including sex determining region Y (SRY)-related high-mobility group (HMG) box (SOX) proteins are thought to be involved in the regulation of specific biological processes. The deregulation of gene expression programs can lead to cancer development. Here, we review the role of the SOX family in breast cancer, prostate cancer, renal cell carcinoma, thyroid cancer, brain tumours, gastrointestinal and lung tumours as well as the entailing therapeutic implications. The SOX family consists of more than 20 members that mediate DNA binding by the HMG domain and have regulatory functions in development, cell-fate decision, and differentiation. SOX2, SOX4, SOX5, SOX8, SOX9, and SOX18 are up-regulated in different cancer types and have been found to be associated with poor prognosis, while the up-regulation of SOX11 and SOX30 appears to be favourable for the outcome in other cancer types. SOX2, SOX4, SOX5 and other SOX members are involved in tumorigenesis, e.g. SOX2 is markedly up-regulated in chemotherapy resistant cells. The SoxF family (SOX7, SOX17, SOX18) plays an important role in angio- and lymphangiogenesis, with SOX18 seemingly being an attractive target for anti-angiogenic therapy and the treatment of metastatic disease in cancer. In summary, SOX transcription factors play an important role in cancer progression, including tumorigenesis, changes in the tumour microenvironment, and metastasis. Certain SOX proteins are potential molecular markers for cancer prognosis and putative potential therapeutic targets, but further investigations are required to understand their physiological functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Items 201–400 of 410
Chakravarty, G., Moroz, K., Makridakis, N. M., Lloyd, S. A., Galvez, S. E., Canavello, P. R., Lacey, M. R., Agrawal, K. C., & Mondal, D. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.010086 · Cited by 86
Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives Glioblastoma
Singh, D. K., Kollipara, R. K., Vemireddy, V., Yang, X.-L., Sun, Y., Regmi, N. L., Klingler, S., Hatanpaa, K. J., Raisanen, J. M., Cho, S. K., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.064 · Cited by 86
Lin, B., Madan, A., Yoon, J., Fang, X., Yan, X. S., Kim, T., Hwang, D., Hood, L., & Foltz, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010210 · Cited by 85
Differential Expression of SOX2 and SOX17 in Testicular Germ Cell Tumors
Nonaka, D. (2009) · American Journal of Clinical Pathology · doi:10.1309/ajcp7mncnbcrn8no · Cited by 85
Peng, X., Liu, G., Peng, H., Chen, A., Zha, L., & Wang, Z. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.12.005 · Cited by 84
SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia
Ramezani-Rad, P., Geng, H., Hurtz, C., Chan, L. N., Chen, Z., Jumaa, H., Melnick, A. M., Paietta, E. M., Carroll, W. L., Willman, C. L., et al. (2012) · Blood · doi:10.1182/blood-2012-05-428938 · Cited by 83
Sox9 mediates Notch1-induced mesenchymal features in lung adenocarcinoma
Capaccione, K. M., Hong, X., Morgan, K. M., Liu, W., Bishop, M. J., Liu, L., Markert, E. K., Deen, M. F., Minerowicz, C., Bertino, J. R., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1970 · Cited by 82
Leung, C. O. N., Mak, W.-N., Kai, A. K., Chan, K. K., Lee, T. K., Ng, I. O., & Lo, R. C. (2016) · Oncotarget · doi:10.18632/oncotarget.8835 · Cited by 82
Sox2 Requirement in Sonic Hedgehog-Associated Medulloblastoma
Ahlfeld, J., Favaro, R., Pagella, P., Kretzschmar, H. A., Nicolis, S. K., & Schüller, U. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0238 · Cited by 81
Wang, S., Tie, J., Wang, R. Y., Hu, F., Gao, L., Wang, W., Wang, L., Li, Z., Hu, S., Tang, S., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.045 · Cited by 80
FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma
Rahmanto, A. S., Savov, V., Brunner, A., Bolin, S., Weishaupt, H., Malyukova, A., Rosén, G., Čančer, M., Hutter, S., Sundström, A., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201693889 · Cited by 80
Targeting SOX2 in anticancer therapy
Hüser, L., Novak, D., Umansky, V., Altevogt, P., & Utikal, J. S. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1538359 · Cited by 80
SoxF Transcription Factors Are Positive Feedback Regulators of VEGF Signaling
Kim, K., Kim, I., Yang, J. M., Lee, E., Koh, B. I., Song, S., Park, J., Lee, S., Choi, C., Kim, J. W., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.308483 · Cited by 79
Karachaliou, N., Rosell, R., & Viteri, S. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2013.01.01 · Cited by 78
Gen, Y., Yasui, K., Nishikawa, T., & Yoshikawa, T. (2013) · Cancer Science · doi:10.1111/cas.12155 · Cited by 77
Zhang, Y., Huang, S., Dong, W., Li, L., Feng, Y., Pan, L., Han, Z., Wang, X., Ren, G., Su, D., et al. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.11.014 · Cited by 77
VEGFD regulates blood vascular development by modulating SOX18 activity
Duong, T., Koltowska, K., Pichol-Thievend, C., Guen, L. L., Fontaine, F. R., Smith, K., Truong, V., Skoczylas, R., Stacker, S. A., Achen, M. G., et al. (2013) · Blood · doi:10.1182/blood-2013-04-495432 · Cited by 77
Distinct Functions of Sox2 Control Self-Renewal and Differentiation in the Osteoblast Lineage
Seo, E., Basu-Roy, U., Zavadil, J., Basilico, C., & Mansukhani, A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05798-11 · Cited by 77
Shepherd, J. H., Uray, I. P., Mazumdar, A., Tsimelzon, A. I., Savage, M. I., Hilsenbeck, S. G., & Brown, P. H. (2016) · Oncotarget · doi:10.18632/oncotarget.7437 · Cited by 77
Chan, D. W., Mak, C. S. L., Leung, T. H. Y., Chan, K. K. L., & Ngan, H. (2012) · Oncotarget · doi:10.18632/oncotarget.667 · Cited by 76
Kang, M., Li, Y., Liu, W., Wang, R., Tang, A., Hao, H., Liu, Z., & Ou, H. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1384 · Cited by 76
TMEM2 Is a SOX4-Regulated Gene That Mediates Metastatic Migration and Invasion in Breast Cancer
Lee, H., Goodarzi, H., Tavazoie, S. F., & Alarcón, C. R. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2322 · Cited by 76
Wang, Y., Zhou, J., Wang, Z., Wang, P., & Li, S. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.09.005 · Cited by 76
Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness
Raspaglio, G., Petrillo, M., Martinelli, E., Puma, D. D. L., Mariani, M., Donato, M. D., Filippetti, F., Mozzetti, S., Prislei, S., Zannoni, G. F., et al. (2014) · Gene · doi:10.1016/j.gene.2014.03.037 · Cited by 75
Hu, J., Tian, J., Zhu, S., Sun, L., Yu, J., Tian, H., Dong, Q., Luo, Q., Jiang, N., Niu, Y., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.372 · Cited by 75
Context-specific role of SOX9 in NF-Y mediated gene regulation in colorectal cancer cells
Shi, Z., Chiang, C.-I., Labhart, P., Zhao, Y., Yang, J., Mistretta, T., Henning, S., Maity, S. N., & Mori–Akiyama, Y. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv568 · Cited by 74
Lessons from the Crypt: HMGA1—Amping up Wnt for Stem Cells and Tumor Progression
Resar, L. M. S., Chia, L., & Xian, L. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3045 · Cited by 74
Wang, H., He, L., Ma, F., Regan, M. M., Balk, S. P., Richardson, A. L., & Yuan, X. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.419184 · Cited by 73
López-Bertoni, H., Lal, B., Michelson, N., Guerrero‐Cazares, H., Quiñones-Hinojosa, A., Li, Y., & Laterra, J. (2016) · Oncogene · doi:10.1038/onc.2016.22 · Cited by 73
Thu, K. L., Radulovich, N., Becker‐Santos, D. D., Pikor, L. A., Pusic, A., Lockwood, W. W., Lam, W. L., & Tsao, M. (2013) · Oncogene · doi:10.1038/onc.2012.595 · Cited by 72
Warnke, E., Pietsch, J., Wehland, M., et al. (2014) · Cell Communication and Signaling · doi:10.1186/1478-811x-12-32 · Cited by 72
Self-citationRole of Notch signaling pathway in pancreatic cancer.
Gao, J., Long, B., & Wang, Z. P. (2017) · Europe PMC (PubMed Central) · Cited by 72
Han, F., Liu, W., JIANG, X. H., Shi, X. A., Yin, L., Ao, L., Cui, Z., Li, Y., Huang, C., Cao, J., et al. (2014) · Oncogene · doi:10.1038/onc.2014.370 · Cited by 71
MicroRNA miR-590-5p inhibits breast cancer cell stemness and metastasis by targeting SOX2.
Zhou, L., Lc, Z., Jiang, N., Wang, X.-L., Xn, Z., Xl, L., & Ren, J. (2017) · PubMed · Cited by 70
Zhong, F., Cheng, X., Sun, S., & Zhou, J. (2017) · Oncology Reports · doi:10.3892/or.2017.5523 · Cited by 70
Basal cell carcinoma: cell of origin, cancer stem cell hypothesis and stem cell markers
Sellheyer, K. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10158.x · Cited by 69
Tong, X., Li, L., Li, X., Lei, H., Zhong, L., Su, X., Rong, R., Hu, S., Liu, W., Jia, B., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2512 · Cited by 69
Kuo, I., Wu, C.-C., Chang, J.-M., Huang, Y., Lin, C., Yan, J.-J., Sheu, B., Lu, P., Chang, W., Lai, W., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28695 · Cited by 69
SOXC proteins amplify canonical WNT signaling to secure nonchondrocytic fates in skeletogenesis
Bhattaram, P., Penzo‐Méndez, A., Kato, K., Bandyopadhyay, K., Gadi, A., Taketo, M. M., & Lefebvre, V. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.201405098 · Cited by 69
MiR‐9 is involved in TGF ‐β1‐induced lung cancer cell invasion and adhesion by targeting SOX 7
Han, L., Wang, W., Ding, W., & Zhang, L. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13120 · Cited by 69
Gershon, T. R., Oppenheimer, O., Chin, S., & Gerald, W. L. (2005) · Neoplasia · doi:10.1593/neo.04637 · Cited by 68
Identification of a human glioma antigen, SOX6, recognized by patients' sera
Ueda, R., Iizuka, Y., Yoshida, K., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1207252 · Cited by 67
Jia, Y., Yang, Y., Zhan, Q., Brock, M. V., Zheng, X., Yu, Y., Herman, J. G., & Guo, M. (2012) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2012.06.004 · Cited by 66
Investigating Breast Cancer Cell Behavior Using Tissue Engineering Scaffolds
Guiro, K., Patel, S. A., Greco, S. J., Rameshwar, P., & Arinzeh, T. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118724 · Cited by 66
Embryonic mammary signature subsets are activated in Brca1 -/- and basal-like breast cancers
Zvelebil, M., Oliemuller, E., Gao, Q., Wansbury, O., Mackay, A. G., Kendrick, H. D., Smalley, M. J., Reis-Filho, J. S., & Howard, B. A. (2013) · Breast Cancer Research · doi:10.1186/bcr3403 · Cited by 66
Han, F., Liu, W., Shi, X., Yang, J., Zhang, X., Li, Z., JIANG, X. H., Li, Y., Li, J., Huang, C., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.04.026 · Cited by 66
SOX2 Promotes Cell Proliferation and Metastasis in Triple Negative Breast Cancer
Liu, P., Tang, H., Song, C.-L., Wang, J., Chen, B., Huang, X.-J., Pei, X., & Liu, L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00942 · Cited by 66
Mou, W., Xu, Y., Ye, Y., Chen, S., Li, X., Gong, K., Liu, Y., Chen, Y., Li, X., Tian, Y., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.004 · Cited by 65
SOXs in human prostate cancer: implication as progression and prognosis factors
Zhong, W., Qin, G., Dai, Q.-S., Han, Z., Chen, S.-M., Ling, X., Fu, X., Cai, C., Chen, J.-H., Chen, X.-B., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-248 · Cited by 65
Ferletta, M., Uhrbom, L., Olofsson, T., Pontén, F., & Westermark, B. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0113 · Cited by 65
MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer
Jiang, J., Zhu, L., Yu, C., Chen, M., Tian, S., & Sun, C. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.007 · Cited by 65
MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9
Liu, N., Zhang, L., Wang, Z., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13706 · Cited by 64
Pharmacological targeting of the transcription factor SOX18 delays breast cancer in mice
Overman, J. P., Fontaine, F. R., Moustaqil, M. D., Mittal, D., Sierecki, E., Sacilotto, N., Zuegg, J., Robertson, A. A. B., Holmes, K. A., Salim, A. A., et al. (2017) · eLife · doi:10.7554/elife.21221 · Cited by 63
Long noncoding RNA lnc-sox5 modulates CRC tumorigenesis by unbalancing tumor microenvironment
Wu, K., Zhao, Z., Liu, K., Zhang, J., Li, G., & Wang, L. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1317416 · Cited by 63
MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer
Wang, Q., Zhou, C.-X., Zhan, M., Tang, J., Wang, C.-L., Ma, C.-N., He, M., Chen, G., He, J., & Zhao, Q. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0715-6 · Cited by 63
The Regulation of SOX7 and Its Tumor Suppressive Role in Breast Cancer
Stovall, D. B., Wan, M., Miller, L. D., Cao, P. D., Maglic, D., Zhang, Q., Stampfer, M. R., Liu, W., Xu, J., & Sui, G. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.07.025 · Cited by 62
The Adverse Effect of Hypertension in the Treatment of Thyroid Cancer with Multi-Kinase Inhibitors
Ancker, O. V., Wehland, M., Bauer, J. W., Infanger, M., & Grimm, D. G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030625 · Cited by 62
Self-citationThe BRG1/SOX9 axis is critical for acinar cell–derived pancreatic tumorigenesis
Tsuda, M., Fukuda, A., Roy, N., Hiramatsu, Y., Leonhardt, L., Kakiuchi, N., Hoyer, K., Ogawa, S., Goto, N., Ikuta, K., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci94287 · Cited by 62
Wang, H., Ping, L., & Zheng, P. (2015) · Oncotarget · doi:10.18632/oncotarget.4133 · Cited by 61
Stratification and therapeutic potential of PML in metastatic breast cancer
Martín-Martín, N., Piva, M., Urosevic, J., Aldaz, P., Sutherland, J. D., Fernández‐Ruiz, S., Arreal, L., Torrano, V., Cortázar, A. R., Planet, E., et al. (2016) · Nature Communications · doi:10.1038/ncomms12595 · Cited by 61
Richtig, G., Aigelsreiter, A., Schwarzenbacher, D., Ress, A. L., Adiprasito, J. B., Stiegelbauer, V., Höefler, G., Schauer, S., Kiesslich, T., Kornprat, P., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187814 · Cited by 61
Expression and Functional Role of Sox9 in Human Epidermal Keratinocytes
Shi, G., Sohn, K., Li, Z., Choi, D.-K., Park, Y. M., Kim, J., Fan, Y., Nam, Y. H., Kim, S., Im, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054355 · Cited by 60
Knockdown of SOX9 Inhibits the Proliferation, Invasion, and EMT in Thyroid Cancer Cells
Huang, J., & Guo, L. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504016x14732772150307 · Cited by 60
Vervoort, S. J., Lourenço, A. R., Vidaković, A. T., Mocholí, E., Sandoval, J. L., Rueda, O. M., Frederiks, C. L., Pals, C. E. G. M., Peeters, J. G. C., Caldas, C., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky755 · Cited by 60
Higuchi, T., Nakayama, T., Arao, T., Nishio, K., & Yoshie, O. (2013) · Blood · doi:10.1182/blood-2012-07-441022 · Cited by 59
Donovan, P., Patel, J., Dight, J., Wong, H. Y., Sim, S.-L., Murigneux, V., François, M., & Khosrotehrani, K. (2018) · Nature Communications · doi:10.1038/s41467-018-07961-w · Cited by 59
SOX-mediated molecular crosstalk during the progression of tumorigenesis
Xu, Y., & Yang, W. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.07.028 · Cited by 58
SOX9-PDK1 axis is essential for glioma stem cell self-renewal and temozolomide resistance
Wang, Z., Xu, X., Liu, N., Cheng, Y., Jin, W., Zhang, P., Wang, X., Yang, H., Liu, H., & Tu, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.22773 · Cited by 58
Li, L., Yang, W., Zheng, P., & Liu, X.-F. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0782-8 · Cited by 58
Sox17 regulates proliferation and cell cycle during gastric cancer progression
Ye, Y., Wu, J., Wang, C.-M., Zhou, Y., Du, C.-Y., Zheng, B.-Q., Cao, X., Zhou, X.-Y., Sun, M.-H., & Shi, Y.-Q. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.03.024 · Cited by 57
SOX17 is a tumor suppressor in endometrial cancer
Zhang, Y., Bao, W., Wang, K., Lu, W., Wang, H., Tong, H., & Wan, X. (2016) · Oncotarget · doi:10.18632/oncotarget.12582 · Cited by 57
Fu, D., Ren, C., Tan, H., Wei, J., Zhu, Y., He, C., Shao, W.-X., & Zhang, J. (2015) · Medicine · doi:10.1097/md.0000000000000637 · Cited by 56
Russo, M. V., Esposito, S., Tupone, M. G., Manzoli, L., Airoldi, I., Pompa, P., Cindolo, L., Schips, L., Sorrentino, C., & Carlo, E. D. (2015) · Oncotarget · doi:10.18632/oncotarget.6029 · Cited by 56
Graham, J., Sm, H., Tran, N. T., et al. (1999) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0220295 · Cited by 56
Structure and decoy-mediated inhibition of the SOX18/Prox1-DNA interaction
Klaus, M., Prokoph, N., Girbig, M., Wang, X., Huang, Y., Srivastava, Y., Hou, L., Narasimhan, K., Kolatkar, P. R., François, M., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw130 · Cited by 56
Neural crest stem cells in melanoma development
Shakhova, O. (2014) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000046 · Cited by 56
Expression of SOX9 and SOX10 in Central Neuroepithelial Tumor
Kordes, U., & Hagel, C. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9180-7 · Cited by 55
Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1
Pei, X., Lv, X., & Li, H. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.109 · Cited by 55
Zhu, H., Tang, J., Tang, M., & Cai, H. (2013) · Diagnostic Pathology · doi:10.1186/1746-1596-8-183 · Cited by 55
miR-132 inhibits lung cancer cell migration and invasion by targeting SOX4.
Li, Y., Zu, L., Wang, Y., Wang, M., Chen, P., & Zhou, Q. (2015) · PubMed · doi:10.3978/j.issn.2072-1439.2015.09.06 · Cited by 55
Role of SoxB1 transcription factors in development
Miyagi, S., Kato, H., & Okuda, A. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0097-0 · Cited by 54
The Role of Sox Genes in Lung Morphogenesis and Cancer
Zhu, Y., Li, Y., Wei, J., & Liu, X. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131215767 · Cited by 54
Huang, H., Cheng, Y.-Y., Liao, W., Tien, Y., Yang, C.-H. J., Hsu, S.-M., & Huang, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048637 · Cited by 54
Thu, K. L., Becker‐Santos, D. D., Radulovich, N., Pikor, L. A., Lam, W. L., & Tsao, M. (2014) · Oncoscience · doi:10.18632/oncoscience.46 · Cited by 54
Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer
Mehta, G., Parker, J. S., Silva, G. O., Hoadley, K. A., Perou, C. M., & Gatza, M. L. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4139-2 · Cited by 54
DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop
Vella, V., Nicolosi, M. L., Cantafio, P., Massimino, M., Lappano, R., Vigneri, P. G., Ciuni, R., Gangemi, P., Morrione, A., Malaguarnera, R., et al. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0310 · Cited by 54
Wang, D., Hao, T., Pan, Y., Qian, X., & Zhou, D. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2315-9 · Cited by 53
Expression of SoxE and SoxD genes in human gliomas
Schlierf, B., Friedrich, R. P., Roerig, P., Felsberg, J., Reifenberger, G., & Wegner, M. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00881.x · Cited by 53
Forced expression of Sox21 inhibits Sox2 and induces apoptosis in human glioma cells
Ferletta, M., Çağlayan, D., Mokvist, L., Jiang, Y., Kastemar, M., Uhrbom, L., & Westermark, B. (2010) · International Journal of Cancer · doi:10.1002/ijc.25647 · Cited by 52
Small-Molecule Inhibitors of the SOX18 Transcription Factor
Fontaine, F. R., Overman, J. P., Moustaqil, M. D., Mamidyala, S. K., Salim, A. A., Narasimhan, K., Prokoph, N., Robertson, A. A. B., Lua, L. H. L., Alexandrov, K. A., et al. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.01.003 · Cited by 52
Dong, P., Yu, B., Pan, L., Tian, X., & Liu, F. (2018) · BioMed Research International · doi:10.1155/2018/2760918 · Cited by 52
Wang, D., Han, S., Wang, X., Peng, R., & Li, X. (2015) · Medical Oncology · doi:10.1007/s12032-014-0461-2 · Cited by 51
SOX7: from a developmental regulator to an emerging tumor suppressor.
Stovall, D. B., Cao, P. D., & Sui, G. (2014) · PubMed · doi:10.14670/hh-29.10.439 · Cited by 51
Shen, Z., Deng, H., Fang, Y., Zhu, X., Ye, G., Li, Y., Liu, H., & Li, G. (2015) · Oncotarget · doi:10.18632/oncotarget.3967 · Cited by 50
Malhotra, G. K., Zhao, X., Edwards, E., Kopp, J. L., Naramura, M., Sander, M., Band, H., & Band, V. (2014) · BMC Developmental Biology · doi:10.1186/s12861-014-0047-4 · Cited by 49
Li, Y., Chen, K., Li, L., Li, R., Zhang, J., & Ren, W. (2015) · Tumor Biology · doi:10.1007/s13277-015-3561-5 · Cited by 48
SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma
Fukazawa, T., Guo, M., Ishida, N., Yamatsuji, T., Takaoka, M., Yokota, E., Haisa, M., Miyake, N., Ikeda, T., Okui, T., et al. (2016) · Scientific Reports · doi:10.1038/srep20113 · Cited by 48
He, J., Shi, J., Zhang, K., Xue, J., Li, J., Yang, J., Chen, J., Wei, J., Ren, H., & Liu, X. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6170 · Cited by 48
Tang, X., Gao, Y., Yu, L., Lu, Y., Zhou, G., Cheng, L., Sun, K., Zhu, B., Xu, M. J., & Liu, J. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0238 · Cited by 48
Ruan, H., Yang, H., Wei, H., Xiao, W., Lou, N., Qiu, B., Xu, G., Song, Z., Xiao, H., Liu, L., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4010 · Cited by 48
SOX9 is a dose-dependent metastatic fate determinant in melanoma
Yang, X., Liang, R., Liu, C., Liu, J. A., Cheung, M. P. L., Liu, X., Man, O. Y., Guan, X.-Y., Lung, H. L., & Cheung, M. C. H. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0998-6 · Cited by 48
Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer
Panza, A., Pazienza, V., Ripoli, M. C., Benegiamo, G., Gentile, A., Valvano, M. R., Augello, B., Merla, G., Prattichizzo, C., Tavano, F., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.04.004 · Cited by 47
Wang, P., Zhao, Y., Fan, R., Chen, T., & Dong, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17070959 · Cited by 47
Utility of Sox10 labeling in metastatic breast carcinomas
Nelson, E. R., Sharma, R. B., Argani, P., & Cimino‐Mathews, A. (2017) · Human Pathology · doi:10.1016/j.humpath.2017.08.011 · Cited by 47
High SOX2 Levels Predict Better Outcome in Non-Small Cell Lung Carcinomas
Velcheti, V., Schalper, K. A., Yao, X., Cheng, H., Kocoglu, M. H., Dhodapkar, K. M., Deng, Y., Gettinger, S. N., & Rimm, D. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061427 · Cited by 46
Decreased expression of SOX6 confers a poor prognosis in hepatocellular carcinoma
Guo, X., Yang, M., Gu, H., Zhao, J., & Zou, L. (2013) · Cancer Epidemiology · doi:10.1016/j.canep.2013.05.002 · Cited by 46
Hong, Y., Chen, W., Du, X., Ning, H., Chen, H., Shi, R., Lin, S., Xu, R., Zhu, J., Wu, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5160 · Cited by 46
STAT3 is Overactivated in Gastric Cancer Stem-Like Cells.
Hajimoradi, M., Hassan, Z. M., Ebrahimi, M., Soleimani, M., Bakhshi, M., Firouzi, J., & Samani, F. S. (2016) · PubMed Central · doi:10.22074/cellj.2016.3834 · Cited by 46
The impact of microgravity-based proteomics research
Grimm, D. G., Pietsch, J., Wehland, M., Richter, P. R., Strauch, S. M., Lebert, M., Magnusson, N. E., Wise, P. M., & Bauer, J. W. (2014) · Expert Review of Proteomics · doi:10.1586/14789450.2014.926221 · Cited by 45
Self-citationRole of miR-145 in human laryngeal squamous cell carcinoma
Karataş, Ö. F., Yücetürk, B., Süer, İ., Yilmaz, M., Cansız, H., Solak, M., Ittmann, M., & Özen, M. (2014) · Head & Neck · doi:10.1002/hed.23890 · Cited by 45
Paradoxical role of SOX2 in gastric cancer.
Carrasco‐García, E., Santos, J. C., García, I., Brianti, M. T., García-Puga, M., Pedrazzoli, J., Matheu, A., & Ribeiro, M. L. (2016) · PubMed Central · Cited by 45
Sox2: regulation of expression and contribution to brain tumors
Mansouri, S., Nejad, R., Karabork, M., Ekinci, C., Solaroğlu, İ., Aldape, K., & Zadeh, G. M. (2016) · CNS Oncology · doi:10.2217/cns-2016-0001 · Cited by 45
Kim, E., Choi, Y. E., Hwang, S. J., Han, Y.-H., Park, M., & Bae, I. H. (2016) · Oncotarget · doi:10.18632/oncotarget.13561 · Cited by 45
SOX5/6/21 Prevent Oncogene-Driven Transformation of Brain Stem Cells
Kurtsdotter, I., Topcic, D., Karlén, A., Singla, B., Hagey, D. W., Bergsland, M., Siesjö, P., Nistér, M., Carlson, J. W., Lefebvre, V., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0704 · Cited by 45
SOX2 as a novel contributor of oxidative metabolism in melanoma cells
Andreucci, E., Pietrobono, S., Peppicelli, S., Ruzzolini, J., Bianchini, F., Biagioni, A., Stecca, B. A., & Calorini, L. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0297-z · Cited by 45
Sahana, J., Nassef, M. Z., Wehland, M., Kopp, S., Krüger, M., Corydon, T. J., Infanger, M., Bauer, J. W., & Grimm, D. G. (2018) · PROTEOMICS · doi:10.1002/pmic.201800015 · Cited by 44
Self-citationThe role of PDGF-B/PDGFR-BETA axis in the normal development and carcinogenesis of the breast
Jitariu, A.-A., Raica, M., Cîmpean, A. M., & Suciu, S. C. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.08.002 · Cited by 44
Puła, B., Olbromski, M., Wojnar, A., Gomułkiewicz, A., Witkiewicz, W., Ugorski, M., Dzięgiel, P., & Podhorska‐Okołów, M. (2013) · Cellular Oncology · doi:10.1007/s13402-013-0151-7 · Cited by 43
Oncogenic activity of SOX1 in glioblastoma
García, I., Aldaregia, J., Marjanović, J., Aldaz, P., Moreno‐Cugnon, L., Torres-Bayona, S., Carrasco‐García, E., Garros-Regulez, L., Egaña, L., Rubio, Á., et al. (2017) · Scientific Reports · doi:10.1038/srep46575 · Cited by 43
Actinomycin D Down-regulates SOX2 Expression and Induces Death in Breast Cancer Stem Cells
Das, T., Nair, R. R., Green, R. J., Padhee, S., Howell, M., Banerjee, J., Mohapatra, S. S., & Mohapatra, S. (2017) · Anticancer Research · doi:10.21873/anticanres.11496 · Cited by 43
SOX11 promotes invasive growth and ductal carcinoma in situ progression
Oliemuller, E., Kogata, N., Bland, P. J., Kriplani, D., Daley, F. M., Haider, S. A., Shah, V., Sawyer, E. J., & Howard, B. A. (2017) · The Journal of Pathology · doi:10.1002/path.4939 · Cited by 43
Ge, Y., Zhou, F., Chen, H., Cui, C., Liu, D., Li, Q., Yang, Z., Wu, G., Sun, S., Gu, J., et al. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.06.015 · Cited by 42
Sodja, E., Rijavec, M., Koren, A., Sadikov, A., Korošec, P., & Čufer, T. (2015) · Radiology and Oncology · doi:10.1515/raon-2015-0027 · Cited by 41
Sox7 promotes high-grade glioma by increasing VEGFR2-mediated vascular abnormality
Kim, I., Kim, K., Lee, E., Oh, D. S., Park, C. S., Park, S., Yang, J. M., Kim, J.-H., Kim, H.-S., Shima, D. T., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20170123 · Cited by 41
Expression of a transcriptional factor, SOX6, in human gliomas
Ueda, R., Yoshida, K., Kawakami, Y., Kawase, T., & Toda, M. (2004) · Brain Tumor Pathology · doi:10.1007/bf02482175 · Cited by 40
SOX4 inhibits GBM cell growth and induces G0/G1 cell cycle arrest through Akt-p53 axis
Zhang, J., Jiang, H., Shao, J., Mao, R., Liu, J., Ma, Y., Fang, X., Zhao, N., Zheng, S. S., & Lin, B. (2014) · BMC Neurology · doi:10.1186/s12883-014-0207-y · Cited by 39
Lin, W. J., Jiang, L., Chen, Y., She, F., Han, S., Zhu, J., Zhou, L., Tang, N., Wang, X., & Li, X. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.09.004 · Cited by 39
Ismail, H. M. (2012) · Journal of Oncology · doi:10.1155/2012/416927 · Cited by 39
Chen, X., Fu, Y., Xu, H., Teng, P., Xie, Q., Zhang, Y., Yan, C., Xu, Y., Li, C., Zhou, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22443 · Cited by 39
Cui, J., Xi, H., Cai, A., Bian, S., Wei, B., & Chen, L. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1759 · Cited by 38
Pietrobono, S., Morandi, A., Gagliardi, S., Gerlini, G., Borgognoni, L., Chiarugi, P., Arbiser, J. L., & Stecca, B. A. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.06.610 · Cited by 38
TRPM7 controls mesenchymal features of breast cancer cells by tensional regulation of SOX4
Kuipers, A. J., Middelbeek, J., Vrenken, K. S., Gonzalez, C. P., Poelmans, G., Klarenbeek, J. B., Jalink, K., Trepat, X., & van Leeuwen, F. N. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.04.017 · Cited by 38
Tchougounova, E., Jiang, Y., Bråsäter, D., Lindberg, N., Kastemar, M., Asplund, A., Westermark, B., & Uhrbom, L. (2009) · Oncogene · doi:10.1038/onc.2009.9 · Cited by 37
The role of Sox6 and Netrin-1 in ovarian cancer cell growth, invasiveness, and angiogenesis
Li, Y., Xiao, M., & Guo, F.-C. (2017) · Tumor Biology · doi:10.1177/1010428317705508 · Cited by 37
Cheng, Q., Wu, J., Zhang, Y., Liu, X., Xu, N., Zuo, F., & Xu, J. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3030 · Cited by 37
SOX3 can promote the malignant behavior of glioblastoma cells
Marjanović, J., Drakulić, D., García, I., Vuković, V., Aldaz, P., Puškaš, N., Nikolić, I., Tasić, G., Raičević, S., Garros-Regulez, L., et al. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0405-5 · Cited by 37
Fu, D., Tan, H., Wei, J., Zhu, C., Jiang, J., Zhu, Y., Cai, F., Chong, M., & Ren, C. (2015) · Tumor Biology · doi:10.1007/s13277-015-3547-3 · Cited by 36
Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma
Matsushima, H., Kuroki, T., Kitasato, A., Adachi, T., Tanaka, T., Hirabaru, M., Hirayama, T., Kuroshima, N., Hidaka, M., Soyama, A., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.08.003 · Cited by 36
Tian, R., Wang, J., Yan, H., Wu, J., Xu, Q., Zhan, X., Gui, Z., Ding, M., & He, J. (2017) · Oncogene · doi:10.1038/onc.2017.182 · Cited by 36
Expression of a SOX1 overlapping transcript in neural differentiation and cancer models
Ahmad, A., Strohbuecker, S., Tufarelli, C., & Sottile, V. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2580-3 · Cited by 36
Sox12 Is a Cancer Stem-Like Cell Marker in Hepatocellular Carcinoma.
Zou, S., Wang, C., Liu, J., Wang, Q., Zhang, D., Zhu, S., Xu, S., Kang, M., & He, S. (2017) · Europe PMC (PubMed Central) · doi:10.14348/molcells.2017.0129 · Cited by 36
Knockdown of SOX12 expression inhibits the proliferation and metastasis of lung cancer cells.
Wang, L., Hu, F., Shen, S., Xiao, H., Li, G., Wang, M., & Mei, J. (2017) · Europe PMC (PubMed Central) · Cited by 36
Oncogenicity of the transcription factor SOX8 in hepatocellular carcinoma
Zhang, S., Zhu, C., Zhu, L., Liu, H., Liu, S., Zhao, N., Wu, J., Huang, X., Zhang, Y., Jin, J., et al. (2014) · Medical Oncology · doi:10.1007/s12032-014-0918-3 · Cited by 35
Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer
Xu, X., Chang, X., Li, Z., Wang, J., Deng, P., Zhu, X.-J., Liu, J., Zhang, C., Chen, S., & Dai, D.-Q. (2015) · Cellular Oncology · doi:10.1007/s13402-015-0219-7 · Cited by 35
Sox8 gene expression identifies immature glial cells in developing cerebellum and cerebellar tumours
Cheng, Y., Lee, C.-J., Badge, R. M., Orme, A. T., & Scotting, P. J. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00147-4 · Cited by 35
SOX5 is involved in balanced MITF regulation in human melanoma cells
Kordaß, T., Weber, C. E. M., Oswald, M., Ast, V., Bernhardt, M., Novak, D., Utikal, J. S., Eichmüller, S. B., & König, R. (2016) · BMC Medical Genomics · doi:10.1186/s12920-016-0170-0 · Cited by 34
SLUG and SOX9 Cooperatively Regulate Tumor Initiating Niche Factors in Breast Cancer
Fazilaty, H., Gardaneh, M., Akbari, P., Zekri, A., & Behnam, B. (2015) · Cancer Microenvironment · doi:10.1007/s12307-015-0176-8 · Cited by 33
SOX 12: a novel potential target for acute myeloid leukaemia
Wan, H., Cai, J., Chen, F., Zhu, J., Zhong, J., & Zhong, H. (2016) · British Journal of Haematology · doi:10.1111/bjh.14425 · Cited by 33
Sox2 is dispensable for primary melanoma and metastasis formation
Schaefer, S. M., Segalada, C., Cheng, P. F., Bonalli, M., Parfejevs, V., Levesque, M. P., Dummer, R., Nicolis, S. K., & Sommer, L. (2017) · Oncogene · doi:10.1038/onc.2017.55 · Cited by 33
Overexpression of Sox3 is Associated with Diminished Prognosis in Esophageal Squamous Cell Carcinoma
Li, K., Wang, R., Jiang, Y., Zou, Y.-B., & Guo, W. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2792-6 · Cited by 32
SOX14 activates the p53 signaling pathway and induces apoptosis in a cervical carcinoma cell line
Ninković, D. S., Petrović, I., Vuković, V., Schwirtlich, M., Gredic, M., Stevanović, M. J., & Popovic, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184686 · Cited by 32
SOX5 interacts with YAP1 to drive malignant potential of non-small cell lung cancer cells.
Zou, H., Wang, S., Wang, S., Wu, H., Yu, J., Chen, Q., Cui, W., Yuan, Y., Wen, X., He, J. W., et al. (2018) · Europe PMC (PubMed Central) · Cited by 32
Chakravarty, G., Rider, B. J., & Mondal, D. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.1.13952 · Cited by 31
Endo, T., & Kobayashi, T. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00067.2013 · Cited by 31
Micro RNA ‐105 targets SOX 9 and inhibits human glioma cell progression
Liu, X., Wang, H., Zhu, Z., Ye, Y., Mao, H., & Zhang, S. (2016) · FEBS Letters · doi:10.1002/1873-3468.12458 · Cited by 31
Sox2‐dependent inhibition of p21 is associated with poor prognosis of endometrial cancer
Yamawaki, K., Ishiguro, T., Mori, Y., Yoshihara, K., Suda, K., Tamura, R., Yamaguchi, M., Sekine, M., Kashima, K., Higuchi, M., et al. (2017) · Cancer Science · doi:10.1111/cas.13196 · Cited by 31
Proteome Analysis of Human Follicular Thyroid Cancer Cells Exposed to the Random Positioning Machine
Bauer, J. W., Kopp, S., Schlagberger, E. M., Grosse, J., Sahana, J., Riwaldt, S., Wehland, M., Lützenberg, R., Infanger, M., & Grimm, D. G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030546 · Cited by 31
Self-citationFHL3 links cell growth and self-renewal by modulating SOX4 in glioma
Han, W., Hu, P., Wu, F., Wang, S., Hu, Y., Li, S., Jiang, T., Qiang, B., & Peng, X. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0152-1 · Cited by 31
High expression of SOX30 is associated with favorable survival in human lung adenocarcinoma
Han, F., Liu, W., Xiao, H., Dong, Y., Sun, L., Mao, C., Li, Y., JIANG, X. H., Lin, A., Cui, Z., et al. (2015) · Scientific Reports · doi:10.1038/srep13630 · Cited by 30
Wu, F., Ye, X., Wang, P., Jung, K., Wu, C., Douglas, D. N., Kneteman, N. M., Bigras, G., Ma, Y., & Lai, R. L. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-317 · Cited by 30
Qu, Y., Zhou, C., Zhang, J., Cai, Q., Li, J., Du, T., Zhu, Z., Cui, X., & Liu, B. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2328 · Cited by 30
The Suppressive Role of SOX7 in Hepatocarcinogenesis
Wang, C., Guo, Y., Wang, J., & Min, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097433 · Cited by 30
SOX18 Is a Novel Target Gene of Hedgehog Signaling in Cervical Carcinoma Cell Lines
Petrović, I., Milivojević, M., Popovic, J., Schwirtlich, M., Ranković, B., & Stevanović, M. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143591 · Cited by 30
Li, W., Wu, D., Niu, Z.-Y., Jiang, D., Ma, H., He, H., Zuo, X., Xie, X., & He, Y. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2704 · Cited by 30
Expression of embryonic stem cell markers in acute myeloid leukemia
Picot, T., Aanei, C. M., Fayard, A., Flandrin‐Gresta, P., Tondeur, S., Gouttenoire, M., Tavernier, E., Wattel, E., Guyotat, D., & Campos, L. (2017) · Tumor Biology · doi:10.1177/1010428317716629 · Cited by 30
Role of miR-613 as a tumor suppressor in glioma cells by targeting SOX9
Sang, Q., Liu, X., & Sun, D. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s156608 · Cited by 30
Liu, Z., Zhong, Y., Chen, Y.-J., & Chen, H. (2018) · Biotechnology and applied biochemistry · doi:10.1002/bab.1718 · Cited by 30
Walter, R. F. H., Mairinger, F. D., Werner, R., Ting, S. C., Vollbrecht, C., Theegarten, D., Christoph, D. C., Zarogoulidis, P., Schmid, K. W., Zarogoulidis, P., et al. (2015) · Future Oncology · doi:10.2217/fon.15.18 · Cited by 29
Ye, X., Wu, F., Wu, C., Wang, P., Jung, K., Gopal, K., Ma, Y., Li, L., & Lai, R. L. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.11.023 · Cited by 29
Gao, J., Zhang, J., Li, Y., et al. (2015) · PubMed · Cited by 29
Expression and correlation of MALAT1 and SOX9 in non‐small cell lung cancer
Chen, W., Zhao, W., Chen, S., Zhang, L., Guo, Z., Wang, L., Wang, J., Wan, Z., Hong, Y., & Yu, L. (2018) · The Clinical Respiratory Journal · doi:10.1111/crj.12906 · Cited by 29
Sox17 inhibits hepatocellular carcinoma progression by downregulation of KIF14 expression
Yang, T., Li, X., Li, L., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-2398-7 · Cited by 27
SOX2 and SOX12 are predictive of prognosis in patients with clear cell renal cell carcinoma
Gu, W., Wang, B., Wan, F., Wu, J., Lü, X., Wang, H., Zhu, Y., Zhang, H., Shi, G., Dai, B., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.7828 · Cited by 27
Caglayan, D., Lundin, E., Kastemar, M., Westermark, B., & Ferletta, M. (2013) · International Journal of Cancer · doi:10.1002/ijc.28147 · Cited by 26
WANG, G., Wei, Z., Jia, H., Zhao, W., Yang, G., & Zhao, H. (2015) · Oncology Reports · doi:10.3892/or.2015.4112 · Cited by 26
MicroRNA‑338‑3p targets SOX4 and inhibits cell proliferation and invasion of renal cell carcinoma
Tong, Z., Meng, X., Wang, J., & Wang, L. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5169 · Cited by 26
Wan, Y., Xi, M., He, H., Song, W., Hua, W., Zen, Z.-C., Liu, Y., Zhou, Y., Mo, R., Zhuo, Y., et al. (2017) · Oncology Research and Treatment · doi:10.1159/000455145 · Cited by 25
Zheng, Y., Sun, Y. J., Liu, Y., Zhang, X., Li, F., Li, L., & Wang, J. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.06.175 · Cited by 25
Bauer, J. W., Wehland, M., Infanger, M., Grimm, D. G., & Gombocz, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082257 · Cited by 25
Self-citationPhi, J. H., Kim, J. H., Eun, K. M., Wang, K., Park, K. H., Choi, S. A., Kim, Y. Y., Park, S., Cho, B.-K., & Kim, S. (2010) · Journal of Neurosurgery Pediatrics · doi:10.3171/2010.2.peds1065 · Cited by 24
MicroRNAs modulate the expression of the SOX18 transcript in lung squamous cell carcinoma
Olbromski, M., Grzegrzółka, J., Jankowska‐Konsur, A., Witkiewicz, W., Podhorska‐Okołów, M., & Dzięgiel, P. (2016) · Oncology Reports · doi:10.3892/or.2016.5102 · Cited by 24
Ruan, H., Hu, S., Zhang, H. Y., Du, G., Li, X., Li, X., & Li, X. (2017) · Oncotarget · doi:10.18632/oncotarget.22635 · Cited by 24
SOX9-mediated upregulation of LGR5 is important for glioblastoma tumorigenicity
Hiraoka, K., Hayashi, T., Kaneko, R., Nasu‐Nishimura, Y., Koyama‐Nasu, R., Kawasaki, Y., & Akiyama, T. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.03.012 · Cited by 23
Yin, H., Qin, C., Zhao, Y., Du, Y., Sheng, Z., Wang, Q., Song, Q., Chen, L., Liu, C., & Xu, T. (2017) · Clinical & Translational Oncology · doi:10.1007/s12094-017-1641-2 · Cited by 23
Expression and significance of SOX2 in non-small cell lung carcinoma
Ying, J., Shi, C., Li, C.-S., Hu, L.-P., & Zhang, W. (2016) · Oncology Letters · doi:10.3892/ol.2016.5065 · Cited by 22
Zhu, Y. T., Jia, Y., Hu, L., Qi, C., Prasad, M. K., McCallion, A. S., & Zhu, Y.-J. (2009) · Biochemical Journal · doi:10.1042/bj20091237 · Cited by 21
Sox9 regulates hyperexpression of Wnt1 and Fzd1 in human osteosarcoma tissues and cells.
Liu, H., Chen, Y., Zhou, F., Jie, L., Pu, L., Ju, J., Li, F., Dai, Z., Wang, X., & Zhou, S. (2014) · Europe PMC (PubMed Central) · Cited by 20
Sox4 Up-Regulates Cyr61 Expression in Colon Cancer Cells
Wu, G., Zhu, Y., & Zhang, J. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000363009 · Cited by 20
Li, Q., Liu, F., Zhang, Y., Fu, L., Wang, C., Chen, X., Guan, S., & Meng, X. (2016) · Oncotarget · doi:10.18632/oncotarget.9145 · Cited by 19
Qin, Y., Wang, F., Miao, Y., Wu, X., Bai, M., Xi, X., & Feng, Y. (2016) · Tumor Biology · doi:10.1007/s13277-016-5095-x · Cited by 18
Kobayashi, Y., Shimizu, T., Naoe, H., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.05.019 · Cited by 17
Erdem, J. S., Skaug, V., Bakke, P. S., Gulsvik, A., Haugen, A., & Zienolddiny, S. (2016) · BMC Cancer · doi:10.1186/s12885-016-2061-3 · Cited by 17
Hu, B., Wang, J., & Jin, X. (2017) · Oncology Letters · doi:10.3892/ol.2017.7160 · Cited by 17
Influence of miR-7a and miR-24-3p on the SOX18 transcript in lung adenocarcinoma
Olbromski, M., Rzechonek, A., Grzegrzółka, J., Glatzel-Plucinska, N. M., Chachaj, A., Werynska, B., Podhorska‐Okołów, M., & Dzięgiel, P. (2017) · Oncology Reports · doi:10.3892/or.2017.6077 · Cited by 17
Characterization of stem‐like cancer cells in basal cell carcinoma and its surgical margins
Marković, M. M., Lazarević, M. M., Toljić, B., Simonović, J., Trišić, D. D., Nikolić, N., Petrović, M., & Milašin, J. (2018) · Experimental Dermatology · doi:10.1111/exd.13755 · Cited by 17
Leiss, L. W., Mutlu, E., Oyan, A. M., Yan, T., Tsinkalovsky, O., Sleire, L., Petersen, K., Rahman, M. A., Johannessen, M., Mitra, S., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3109-8 · Cited by 15
Prognostic significance of PIK3CA and SOX2 in Asian patients with lung squamous cell carcinoma
Iijima, Y., Seike, M., Noro, R., IBI, T., Takeuchi, S., Mikami, I., Koizumi, K., Usuda, J., & Gemma, A. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2742 · Cited by 14
Increased expression of sex determining region Y-box 11 ( SOX11 ) in cutaneous malignant melanoma
Jian, J., Guoying, W., & Zhao, J. Y. (2013) · Journal of International Medical Research · doi:10.1177/0300060513476592 · Cited by 13
Targeting SOX9 for degradation to inhibit chemoresistance, metastatic spread, and recurrence
Rahmanto, A. S., Swartling, F. J., & Sangfelt, O. (2016) · Molecular & Cellular Oncology · doi:10.1080/23723556.2016.1252871 · Cited by 13
In Vitro Characterization of Stem Cell-Like Properties of Drug-Resistant Colon Cancer Subline
Yang, D., Wang, H., Zhang, J., Li, C., Lu, Z., Liu, J., Lin, C., Li, G., & Qian, H. (2013) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504013x13793555706768 · Cited by 12
Cited by
Hallmarks of Cancer: New Dimensions
Hanahan, D. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1059 · Cited by 9,887
Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states
Simeonov, K. P., Byrns, C. N., Clark, M. L., Norgard, R. J., Martin, B., Stanger, B. Z., Shendure, J., McKenna, A., & Lengner, C. J. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.05.005 · Cited by 385
Lymph node colonization induces tumor-immune tolerance to promote distant metastasis
Reticker-Flynn, N. E., Zhang, W., Belk, J. A., Basto, P. A., Escalante, N. K., Pilarowski, G. O. W., Bejnood, A., Martins, M. M., Kenkel, J. A., Linde, I. L., et al. (2022) · Cell · doi:10.1016/j.cell.2022.04.019 · Cited by 385
Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis
Guccini, I., Revandkar, A., D'Ambrosio, M., Colucci, M., Pasquini, E., Mosole, S., Troiani, M., Brina, D., Sheibani-Tezerji, R., Elia, A. R., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.10.012 · Cited by 185
Sox13 promotes hepatocellular carcinoma metastasis by transcriptionally activating Twist1
Feng, M., Fang, F., Fang, T., Jiao, H., You, S., Wang, X., & Zhao, W. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-0445-0 · Cited by 25
Metadata
- Authors
- Grimm, D., Bauer, J., Wise, P., Krüger, M., Simonsen, U., Wehland, M., Infanger, M., & Corydon, T. J.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 67
- Issue
- Pt 1
- Pages
- 122-153
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2925334213
- Cited by
- 487
- References
- 410
- FWCI
- 13.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.